Related Experiment Video
Updated: Oct 13, 2025
Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
Published on: February 26, 2013
A tale of two balloons: technical and procedural difference between cryoballoon systems.
Emrie Tomaiko-Clark1, Rong Bai1, Mateen Khokhar2
1Banner University Medical Center Phoenix.
The new POLARx cryoballoon catheter offers design improvements for atrial fibrillation treatment. Its stable balloon size and pressure aim to enhance occlusion and procedural success.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Cryoballoon ablation is an established treatment for atrial fibrillation.
- The Medtronic Arctic Advance is the most common cryoballoon catheter used.
- Boston Scientific has introduced the POLARx cryoballoon catheter.
Purpose of the Study:
- To review the design modifications of the POLARx cryoballoon catheter.
- To discuss the implications of these changes for clinical practice.
Main Methods:
- Review of published literature and device specifications.
- Analysis of early clinical experiences with the POLARx system.
Main Results:
- The POLARx cryoballoon catheter is approved in Europe.
- Initial studies demonstrate in vivo clinical experiences with the new technology.
Conclusions:
- The POLARx catheter's design, especially its consistent balloon size and pressure, is expected to improve lesion quality.
- These improvements theoretically enhance procedural outcomes in atrial fibrillation ablation.
More Related Videos
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015
04:10Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
Published on: July 19, 2024